Sanofi Tells Justices It Couldn't Give Away EpiPen Rival
By Nadia Dreid ( March 22, 2023, 8:37 PM EDT) -- Sanofi-Aventis says it's high time for the U.S. Supreme Court to shed some light on how exclusive dealing relates to monopolization and that its antitrust suit against Mylan over Sanofi's failed EpiPen rival is the perfect vehicle to do that....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.